tilorone has been researched along with Leukemia, Lymphocytic in 2 studies
Tilorone: An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.
tilorone : A member of the class of fluoren-9-ones that is 9H-fluoren-9-one which is substituted by a 2-(diethylamino)ethoxy group at positions 2 and 7. It is an interferon inducer and a selective alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist. Its hydrochloride salt is used as an antiviral drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiCioccio, RA | 1 |
| Sahai Srivastava, BI | 1 |
| Melekhin, VD | 1 |
| Siniachenko, VV | 1 |
| Andronati, SA | 1 |
| Litvinova, LA | 1 |
| Ostrovskiĭ, KG | 1 |
2 other studies available for tilorone and Leukemia, Lymphocytic
| Article | Year |
|---|---|
Inhibition of deoxynucleotide-polymerizing enzyme activities of human leukemia lymphoblasts and simian sarcoma virus by tilorone and thirteen of its analogs.
Topics: DNA; DNA Nucleotidyltransferases; DNA-Directed DNA Polymerase; Fluorenes; Humans; In Vitro Technique | 1978 |
[Pathogenetic heterogeneity of chronic lympholeukemia and the possibilities for its immunotherapy].
Topics: Aged; Female; Humans; Immunity, Cellular; Immunotherapy; Leukemia, Lymphoid; Leukocyte Count; Levami | 1988 |